India · Delayed Price · Currency is INR Dr. Lal PathLabs Statistics
Total Valuation
NSE:LALPATHLAB has a market cap or net worth of INR 282.80 billion. The enterprise value is 271.81 billion.
| Market Cap | 282.80B |
| Enterprise Value | 271.81B |
Important Dates
The next confirmed earnings date is Friday, July 24, 2026.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
NSE:LALPATHLAB has 167.06 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 167.06M |
| Shares Outstanding | 167.06M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 54.43% |
| Owned by Institutions (%) | 33.41% |
| Float | 75.68M |
Valuation Ratios
The trailing PE ratio is 56.05 and the forward PE ratio is 47.89. NSE:LALPATHLAB's PEG ratio is 3.37.
| PE Ratio | 56.05 |
| Forward PE | 47.89 |
| PS Ratio | 10.24 |
| PB Ratio | 11.13 |
| P/TBV Ratio | 16.00 |
| P/FCF Ratio | 60.35 |
| P/OCF Ratio | 44.49 |
| PEG Ratio | 3.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.82, with an EV/FCF ratio of 58.01.
| EV / Earnings | 53.85 |
| EV / Sales | 9.84 |
| EV / EBITDA | 34.82 |
| EV / EBIT | 43.44 |
| EV / FCF | 58.01 |
Financial Position
The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.48 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.42 |
| Interest Coverage | 27.45 |
Financial Efficiency
Return on equity (ROE) is 21.47% and return on invested capital (ROIC) is 35.50%.
| Return on Equity (ROE) | 21.47% |
| Return on Assets (ROA) | 13.34% |
| Return on Invested Capital (ROIC) | 35.50% |
| Return on Capital Employed (ROCE) | 23.22% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | 5.31M |
| Profits Per Employee | 969,610 |
| Employee Count | 5,206 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 27.99 |
Taxes
In the past 12 months, NSE:LALPATHLAB has paid 1.59 billion in taxes.
| Income Tax | 1.59B |
| Effective Tax Rate | 23.81% |
Stock Price Statistics
The stock price has increased by +14.25% in the last 52 weeks. The beta is 0.19, so NSE:LALPATHLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +14.25% |
| 50-Day Moving Average | 1,613.36 |
| 200-Day Moving Average | 1,502.71 |
| Relative Strength Index (RSI) | 59.96 |
| Average Volume (20 Days) | 766,439 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:LALPATHLAB had revenue of INR 27.63 billion and earned 5.05 billion in profits. Earnings per share was 30.20.
| Revenue | 27.63B |
| Gross Profit | 16.44B |
| Operating Income | 6.26B |
| Pretax Income | 6.69B |
| Net Income | 5.05B |
| EBITDA | 7.41B |
| EBIT | 6.26B |
| Earnings Per Share (EPS) | 30.20 |
Balance Sheet
The company has 13.31 billion in cash and 1.99 billion in debt, with a net cash position of 11.32 billion or 67.75 per share.
| Cash & Cash Equivalents | 13.31B |
| Total Debt | 1.99B |
| Net Cash | 11.32B |
| Net Cash Per Share | 67.75 |
| Equity (Book Value) | 25.41B |
| Book Value Per Share | 150.21 |
| Working Capital | 11.16B |
Cash Flow
In the last 12 months, operating cash flow was 6.36 billion and capital expenditures -1.67 billion, giving a free cash flow of 4.69 billion.
| Operating Cash Flow | 6.36B |
| Capital Expenditures | -1.67B |
| Depreciation & Amortization | 1.15B |
| Net Borrowing | -367.55M |
| Free Cash Flow | 4.69B |
| FCF Per Share | 28.05 |
Margins
Gross margin is 59.49%, with operating and profit margins of 22.65% and 18.27%.
| Gross Margin | 59.49% |
| Operating Margin | 22.65% |
| Pretax Margin | 24.22% |
| Profit Margin | 18.27% |
| EBITDA Margin | 26.80% |
| EBIT Margin | 22.65% |
| FCF Margin | 16.96% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | -8.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.42% |
| Buyback Yield | -0.19% |
| Shareholder Yield | 0.76% |
| Earnings Yield | 1.78% |
| FCF Yield | 1.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:LALPATHLAB is 1,713.88, which is -0.65% lower than the current price. The consensus rating is "Buy".
| Price Target | 1,713.88 |
| Price Target Difference | -0.65% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 12.92% |
| EPS Growth Forecast (3Y) | 15.78% |
Stock Splits
The last stock split was on December 19, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Dec 19, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NSE:LALPATHLAB has an Altman Z-Score of 27.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 27.45 |
| Piotroski F-Score | 6 |